EMJ Podcast: Insights For Healthcare Professionals

The EMJ Podcast is an educational podcast for healthcare professionals that covers the forefront of clinical practice, offering insights into the cutting edge of medicine. Through conversations with key opinion leaders, our hosts explore the latest trends and innovations, covering a number of clinical specialties, including oncology, dermatology, urology, cardiology, and many more.

EMJ Podcast: Insights For Healthcare Professionals is a education podcast hosted by Unknown Host, with 0 episodes on record and a Required Pod Score of 80.

Unknown Host hosts EMJ Podcast: Insights For Healthcare Professionals, a education show with 0 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  EMJ Podcast: Insights For Healthcare Professionals

  Modern Lipidology in CVD Prevention: Finding Families at Risk

  Sep 27, 202611 minS1

  Professor Devaki Nair joins host Catherine Glass to discuss why familial hypercholesterolaemia remains underdiagnosed despite increasing awareness. Learn how genetic testing, cascade screening, and specialist lipid clinics are helping clinicians identify high-risk families earlier and improve the prevention of premature cardiovascular disease. Timestamps: 00:00 – 00:52: Introduction 00:52 – 04:50: Diagnostic Barriers 04:50 – 06:18: Genetic Testing 06:18 – 08:15: Screening Barriers 08:15 – 10:04: Lesson Learned 10:04 – 11:02: New Developments

  ListenShow Notes
• 

  EMJ Podcast: Insights For Healthcare Professionals

  Quickfire: Modern Lipidology in CVD Prevention

  Sep 27, 202612 minS1

  In this rapid-fire episode, Professor Devaki Nair answers key questions on cardiovascular prevention, cholesterol, Lipoprotein(a), familial hypercholesterolaemia, and the future of lipidology. Discover the biggest challenges, emerging trends, and opportunities shaping preventive cardiology in just a few minutes.

  ListenShow Notes
• 

  EMJ Podcast: Insights For Healthcare Professionals

  FIT, Colonoscopy and the Future of Colorectal Cancer Screening: The Future of Screening and Early Diagnosis

  Sep 23, 202611 minS1

  In the final episode of this series on colorectal cancer screening, Matt Rutter explores the future of early diagnosis and prevention. From AI in endoscopy and personalised screening pathways to emerging technologies and unanswered research questions, this episode looks at how innovation could transform bowel cancer detection and prevention over the next decade. Timestamps: 58:09 – Innovations in colorectal cancer detection 05:10 – Personalised screening pathways 06:15 – Unanswered questions in colorectal cancer screening research 07:25 – One major change for healthcare systems to improve screening outcomes 07:57 – Colorectal cancer screening in 10–15 years 9:05 – The next 5 years in bowel screening, FIT testing, and colonoscopy practice

  ListenShow Notes
• 

  EMJ Podcast: Insights For Healthcare Professionals

  FIT, Colonoscopy and the Future of Colorectal Cancer Screening: FIT, Colonoscopy, and Quality in Detection

  Sep 23, 202618 minS1

  How do faecal immunochemical tests and colonoscopy work together to improve colorectal cancer detection? In Part 2, Matt Rutter discusses the importance of quality in endoscopy, including colonoscopy performance indicators, interval cancers, variation in outcomes, and the role of large-scale data in improving screening pathways. This episode highlights why quality improvement remains central to preventing colorectal cancer. Timestamps 01:08 – Endoscopy quality 03:18 – Colonoscopy quality indicators 04:56 – Variations between colonoscopy providers 08:05 – The National Endoscopy Database 10:16 – Interval cancers 13:53 – Interpreting FIT Results

  ListenShow Notes
• 

  EMJ Podcast: Insights For Healthcare Professionals

  Optimizing Outcomes for Central Nervous System Metastases in EGFR-Mutated Advanced Non-small Cell Lung Cancer

  Sep 22, 202634 min

  This episode has been funded by AstraZeneca and is intended for healthcare professionals. All content has been developed independently by AMJ, and AstraZeneca has had no influence over the content of this podcast. The views expressed are those of the participating experts and do not necessarily reflect the views of AMJ or AstraZeneca. This material is intended for educational and scientific exchange purposes only. Thoracic medical oncologist Julia Rotow and neuro-oncologist David O. Kamson discuss how they manage central nervous system metastases in EGFR-mutated advanced non-small cell lung cancer. They begin with brain metastases found at diagnosis, and how the current frontline regimens have changed the decision between systemic therapy with MRI surveillance, upfront stereotactic radiosurgery, and, for some patients, both. They also explain where whole brain radiotherapy now sits in their own practice. The speakers then discuss leptomeningeal disease: why it is often recognized late, what they add to the standard workup, and the symptoms that make them worry about hydrocephalus and cauda equina involvement. They review systemic and local options after progression on a third-generation tyrosine kinase inhibitor, and close with where they each see the biggest gap in current central nervous system management. Speakers David O. Kamson, Johns Hopkins University, Baltimore, Maryland, USA Julia Rotow, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

  ListenShow Notes

Recent guests on EMJ Podcast: Insights For Healthcare Professionals. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.